Article
Evaluation of plasma brain-derived neurotrophic factor levels and self-perceived cognitive impairment post-chemotherapy: a longitudinal study.
BMC cancer - 19 Dec 2017
Ng Terence, Lee Ying Yun, Chae Jung-Woo, Yeo Angie Hui Ling, Shwe Maung, Gan Yan Xiang, Ng Raymond C H, Chu Pat Pak Yan, Khor Chiea Chuen, Ho Han Kiat, Chan Alexandre
Abstract excerpt
BACKGROUND: Preliminary evidence suggests that changes in plasma brain-derived neurotrophic factor (BDNF) levels may contribute to the occurrence of chemotherapy-associated cognitive impairment (CACI), and a previous study suggested that carriers of the BDNF Met homozygous genotype are protected from CACI. METHODS: This multicenter, prospective cohort study involved chemotherapy-receiving early-stage breast...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
